Chu: Virtual cell models lag due to high-quality data limitations
Ci Chu · 🔬Causal Models Need Causal Data - Xaira’s X-Cell model (Bo Wang & Ci Chu) · Jul 21, 2026 · at 9:46
Ci Chu, Chief Discovery Officer at Xaira Therapeutics, discusses the primary bottlenecks preventing virtual cell and clinical models from matching the success of protein design AI.
0:00 / 0:12exact quote · 12.6s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“In the other domains, such as clinical model prediction, such as virtual cell, we are nowhere near the same kind of massive data that are high quality, and I think it's mainly a data limitation issue.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Ci Chu
Chu: Descriptive Models Fail to Beat Linear Baselines on Causal Biology
“Models that are trained on descriptive data do not yet outperform linear models on causal tasks, perturbational tasks, what we call counterfactual tasks.”
Chu: Observational Profiling Data Cannot Learn Biological Causality
“Fundamentally, we believe our provisional data are underpowered to learn causality, truly.”
Chu: X-Cell Predicts Perturbation Effects In Unseen Activated T Cells
“Critically, Excel has not seen active cell T cells. And it's able to make accurate prediction, not only on the known biology, the TCR complex, predicting their effect accurately, that these are going to inactive the T cells, which It's exactly what we would ex…”
Chu: Xaira is first to combine seven genome-wide Perturb-seq campaigns
“It is the first time that someone can put together not just one perturbseek, but seven genome-wide perturbseek campaigns together.”
Chu: Academia drives accidental discovery while industry excels at scaling data
“These innovations take so long and the discovery process can be so accidental, right, that It's perhaps not ideal for pure industry to take on, but once they show early promise, scaling them, and robustifying them, and generating data that's not only massive, …”